The 20 Best Retinopathy Pigmentary Mental Retardation Doctors Near Me in Bronx, NY

Omar Saeed, MD, is an Attending Cardiologist at Montefiore and Assistant Professor of Medicine at our Albert Einstein College of Medicine. His clinical focus is on heart failure, heart transplantation and mechanical circulatory support. Dr. Saeed is rated as an Advanced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Heart Failure, Hemolysis, Arteriovenous Malformation, Heart Transplant, and Hormone Replacement Therapy (HRT).

Carol B. Kelly, MD, is an attending internal medicine physician and Assistant Professor, Medicine at Montefiore Einstein. Her clinical focus centers on teaching the next generation of internal medicine residents how to be skilled and compassionate primary care physicians. Dr. Kelly is rated as an Experienced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. Her clinical expertise encompasses Type 2 Diabetes (T2D), Hypertension, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Dr. Marion is Executive Director of the Children’s Evaluation and Rehabilitation Center and the University Center of Excellence in Developmental Disabilities at the Rose F. Kennedy Center. He is Chief of the Divisions of Genetics and of Development Medicine at the Children’s Hospital at Montefiore and Director of the Center for Congenital Disorders. A faculty member at Einstein since 1984, Dr. Marion’s interests include the natural history and genetic basis of multiple malformation syndromes. At The Children’s Hospital at Montefiore he has served as Medical Director of the Spina Bifida Center for 20 years, is the founder and Medical Director of the Williams Syndrome Center, and helped organize the Center for CardioG enetics, the Neurofibromatosis Center, and the Center for Excellence in Autism. He has published extensively in the medical literature in these areas and, in addition, is the author of seven books. Dr. Marion is rated as an Experienced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome), Mucopolysaccharidosis Type 7 (MPS VII, Sly Syndrome), N-Acetyl-Alpha-D-Galactosaminidase Deficiency Type 3, and Mucopolysaccharidoses (MPS).

Dr Krishnan initially did her medical school, residency, and fellowship training in India. Subsequent to that she moved to the United States to complete her pediatrics residency at New York medical college and her Pediatric Cardiology fellowship at Columbia University. She then returned to India to head the Department of Pediatric Cardiology at the Institute of Cardiovascular Diseases and Madras Medical Mission in Chennai India. She set up the first fellowship program, training Indian and international fellows in Pediatric Cardiology in India and getting accreditation for Pediatric Cardiology with the National board of Education in New Delhi. She also co-founded the Pediatric Cardiology Society of India. In 2001 Dr Krishnan moved back to New York to take a faculty position at New York Medical College. She left there is 2010 to take a position at Columbia University in 2010 where she is currently. She is an Associate Professor of Pediatrics as well as an Associate Medical Director of the Pediatric Pulmonary Hypertension Center which is the first accredited pediatric and adult pulmonary hypertension center in the United States. In addition to clinical responsibilities, she is actively involved in medical education at every level. She is closely involved with the Pediatric Cardiology fellowship at Columbia University and is the director of the fellowship Clinical Competency Committee, which oversees fellow education and training. She is the director of medical student and resident education in Pediatric Cardiology and is closely involved with the Foundations in Clinical Medicine and Major Clinical Year training at the medical school. She was inducted to the Virginia Apgar Society of Medical Educators at Columbia University in 2018.She is also actively involved in research, both in Pulmonary Hypertension and Pediatric Cardiology and is PI/co-investigator in multiple clinical trials, both NIH sponsored and other grants. She has co-authored over 50 papers and has multiple invited lectures to her credit. She is actively involved in the Pediatric Pulmonary Hypertension Network and in multiple research activities of the network. She is involved in curriculum development for a Pulmonary Hypertension education series. She is involved in teaching e-learning courses for international fellows in Pediatric Cardiology through the Children’s heart link. She is on the editorial board of several journals including the Annals of Pediatric Cardiology and the Advances in Pulmonary Hypertension, and is a reviewer for multiple other journals. Dr. Krishnan is rated as an Experienced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses High Blood Pressure in Infants, Pulmonary Vein Stenosis, Pulmonary Hypertension, Gastrostomy, and Endoscopy. Dr. Krishnan is board certified in Pediatric Cardiology. Dr. Krishnan is currently accepting new patients.

Elona Dhrami is an Ophthalmologist practicing medicine in Bronx, New York. Dr. Dhrami is rated as an Experienced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Color Blindness, Kallikrein Hypertension, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Vitrectomy.

Pier Leone is a Cardiologist practicing medicine in Bronx, New York. Dr. Leone is rated as an Experienced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Coronary Heart Disease, Heart Attack, Angioplasty, and Transcatheter Aortic Valve Replacement (TAVR).

Dulce Gonzalez is a primary care provider, practicing in Pediatrics in Bronx, New York. Dr. Gonzalez is rated as an Experienced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Parainfluenza, Parainfluenza Virus Type 3, Genetic Epilepsy with Febrile Seizures Plus (GEFS+), and Viral Gastroenteritis.

Scott E. Brodie, MD, Ph.D., is a Professor of Clinical Ophthalmology and Attending Ophthalmologist in the Department of Ophthalmology. He is an internationally known clinician-scientist, and a leader in the use of electrophysiologic techniques for diagnosing of visual impairments in children and adults.Dr. Brodie is a graduate of the combined MD-PhD program at Weill-Cornell Medical College and The Rockefeller University in New York. He completed his PhD in retinal physiology in the laboratory of Nobel Laureate H. K. Hartline, under the supervision of Dr. Floyd Ratliff and Prof. Bruce Knight. He completed a medical internship and residency training in ophthalmology at The New York Hospital, and subsequently received fellowship training in medical retinal disorders and clinical electrophysiology of vision at New York University and Bellevue Hospital under the supervision of Dr. Ronald Carr, with support as a John Kluge Fellow of the Retinitis Pigmentosa Foundation.He is a fellow of the American Academy of Ophthalmology, and a fellow of the Association for Research in Vision and Ophthalmology. He is a member of the International Society for Clinical Electrophysiology of Vision, the International Society for Genetic Eye Disease, and the Ophthalmic Genetics Study Club. Dr. Brodie has been honored with the Senior Achievement Award of the American Academy of Ophthalmology, as well as the Academy's Secretariat Award for Education.Dr. Brodie’s research centers on improving methodologies for electrophysiologic testing, and descriptions of novel findings in patients with inherited and metabolic retinal disorders. He has been a key member of the teams which have introduced important new therapies, including enzyme-replacement therapy for Fabry disease, and intra-arterial chemotherapy for retinoblastoma, which has increased the rate of salvage of diseased eyes in the most severely affected patients from 20% to over 90%.Dr. Brodie has published extensively on electrophysiology and retinal disorders. He has a particular interest in clinical optics, and has served as Chair of the Editorial committee for the American Academy of Ophthalmology’s Basic and Clinical Science Course on Clinical Optics for the past ten years. In his spare time, he enjoys reading mathematics, and playing the oboe in local orchestras and chamber groups. Dr. Brodie is rated as an Advanced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Retinitis Pigmentosa, Cone-Rod Dystrophy, Retinopathy Pigmentary Mental Retardation, and Vitrectomy. Dr. Brodie is currently accepting new patients.

Tongalp H. Tezel, MD is the Chang Family Endowed Professor of Ophthalmology and the Director of the Vitreoretinal Service and Fellowship Program at the Department of Ophthalmology. Dr. Tezel is an internationally known clinician-scientist and a leader in the management of vitreoretinal diseases. Dr. Tezel received his medical degree and initial ophthalmology training in Ankara, Turkey at Hacettepe University, School of Medicine, and completed his ophthalmology residency at Washington University School of Medicine. He later trained under Dr. Stanley Chang and received his fellowship in vitreoretinal surgery here at Columbia University.He is a fellow of the American Academy of Ophthalmology, American Society of Retina Specialists, the Macula Society, The Retina Society, and the Association for Research in Vision and Ophthalmology. He has received numerous honors, including the Fellow of the Association for Research in Vision and Ophthalmology (FARVO), American Academy of Ophthalmology's Achievement Award, Alpha Omega Alpha Faculty Membership; Honor Award of the American Society of Retina Specialist, and several Awards for Excellence in Teaching. He is listed on the Best Doctors of America and Castle Connolly's Top Doctor Directory.Dr. Tezel's research laboratory focuses on investigating the molecular mechanisms of various retinal diseases. His main research interests include gene therapy for age-related macular degeneration, inherited retinal diseases, retinal stem cell transplantation, angiogenesis, pharmacologic vitreolysis, and tissue engineering. He has developed several techniques used for tissue engineering and retinal cell replacement therapies, awarded numerous patents for his contributions. Recently, he has embarked on gene treatment and tissue engineering trials for macular degeneration.Dr. Tezel is an ad-hoc reviewer for several journals in his field and has been contributing to the development of the vitreoretinal field with several publications, presentations, and invited lectures. Dr. Tezel is rated as an Advanced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, Central Serous Chorioretinopathy, and Vitrectomy. Dr. Tezel is board certified in Ophthalmology. Dr. Tezel is currently accepting new patients.

Benjamin Mantell is a Pediatric Cardiologist practicing medicine in New York,, New York. Dr. Mantell is rated as an Experienced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Duchenne Muscular Dystrophy, Mitral Atresia, Hypoplastic Left Heart Syndrome (HLHS), Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), and Heart Transplant.

Dr. Ian Daniel Krantz, MD, is a renowned physician specializing in Genetics and Pediatrics. He currently sees patients at Cohen Children's Medical Center (CCMC) and Northwell Health Physician Partners Medical Genetics. Dr. Krantz holds certifications in Clinical Genetics, Cytogenetics, and Pediatrics from the American Board of Medical Genetics and the American Board of Pediatrics, respectively.Dr. Krantz completed his BFA at Concordia University in Montreal and his MD at Sackler School of Medicine (Tel Aviv University). He completed his residency in Medical Genetics at Children's Hospital of Philadelphia and his residency in Pediatrics at New York University Medical Center.With an impressive set of academic and administrative titles, Dr. Krantz serves as the Division Chief of Pediatric Genetics and Genomics at Cohen Children's Medical Center and is the System Vice President for Pediatric Genetics at Northwell Health. Additionally, he holds the position of Professor at the Zucker School of Medicine at Northwell Health.Dr. Krantz is recognized for his clinical expertise in isolated and syndromic forms of congenital birth differences and developmental diagnoses, including syndromic and non-syndromic autism. He has a special interest in the genetics of hearing loss and focused expertise in Cornelia de Lange Syndrome, Pallister-Killian syndrome, Alagille syndrome, CHOPS syndrome, among others.Dr. Krantz's research is dedicated to identifying and characterizing the molecular etiology of syndromic and non-syndromic developmental diagnoses. His research lab has made significant contributions in the field, discovering new disease genes and shedding light on critical molecular pathways involved in human developmental disorders.Driven by his commitment to advancing patient care, Dr. Krantz has been at the forefront of integrating genomic technologies into the clinical setting. He has implemented rapid genome sequencing into the NICU and CICU and established biobanks and biorepositories to further research efforts. Through his work, he aims to understand the impact of complex diagnostic information on clinicians and families involved.With his extensive expertise and dedication to advancing genetic research and patient care, Dr. Krantz continues to make significant contributions to the field of Pediatrics and Genetics. Dr. Krantz is rated as an Advanced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Cornelia De Lange Syndrome, Pallister-Killian Mosaic Syndrome, Mosaicism, and KBG Syndrome.

Leejee Suh is an Ophthalmologist practicing medicine in New York, New York. Dr. Suh is rated as an Experienced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Cataract, Keratoconus, Interstitial Keratitis, Vitrectomy, and Cataract Removal. Dr. Suh is board certified in Ophthalmology. Dr. Suh is currently accepting new patients.

"Stephen H. Tsang, M.D, Ph.D. is an acclaimed clinical geneticist in the care of individuals with retinal degenerations. He has been culturing stem cells since 1992 and created the first mouse model for a recessive form of retinitis pigmentosa (RP) by applying genome engineering to stem cell technology in 1995. He successfully treated preclinical models of Pde6a, Pde6b, Mfrp, Rho, Cngb1 and autosomal recessive bestrophin retinopathies.He has expertise in designing and testing genome engineering strategies in pre-clinical models, developing patient-specific knock-in models, generating of patient cell lines and providing care to patients with a precision medicine approach. He is also leading efforts in FDA trials for gene therapies, including PDE6A, RAB geranylgeranyl transferase, RPGR, CNGB3, CNGA3 and ABCA4 retinopathies. He wrote 3 books: “Precision Medicine, CRISPR, and Genome Engineering: Moving from Association to Biology and Therapeutics"" and “Stem Cell Biology and Regenerative Medicine in Ophthalmology”, Springer Press, NY; and “CRISPR Genome Surgery in Stem Cells and Disease Tissues”, Elsevier Inc. He is an elected member of several honorary societies including the American Society for Clinical Investigation, Alcon Research Institute and American Ophthalmological Society. He is consistently named to various NIH study sections (DPVS standing member 2014-8 and PED2 2022-6) and other review committees; Alcon Research Institute Grant Review Committee (2022-27), Scientific Advisory Panel - Research to Prevent Blindness (RPB, 2019-29), Chair of American Ophthalmological Society Thesis Review Committee (2022-2023). Many of his publications are in widely-read general interest journals such as Science, NEJM, Lancet, Cell Stem Cell, Nature Genetics, and Journal of Clinical Investigation, which attests to the broad impact that his work has had.Dr. Tsang received a resident teaching award in 2008 and was the Columbia Ophthalmology Basic Science Course Director (2006-2018). Dr. Tsang graduated from Johns Hopkins University, where he began his medical genetics training under the tutelage of Professor Victor A. McKusick. He received his M.D. and Ph.D. degrees from the NIH-National Institute of General Medical Sciences Medical Scientist Training Program (MSTP) at Columbia University. Dr. Tsang then completed his residency at Jules Stein Eye Institute/UCLA, followed by studies with Professors Alan C. Bird and Graham E. Holder on improving the care of individuals with macular degenerations.". Dr. Tsang is rated as an Experienced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Leber Congenital Amaurosis, Sorsby Fundus Dystrophy, Stargardt Macular Degeneration, and Usher Syndrome. Dr. Tsang is board certified in Ophthalmology. Dr. Tsang is currently accepting new patients.

Alejandro Iglesias, MD is Assistant Professor of Pediatrics, Director of the Inherited Metabolic Program, Program Director of the Medical Genetics Residency program and Attending Physician in the Division of Medical Genetics, Department of Pediatrics at New York Presbyterian Hospital/Columbia University Medical Center. He is a clinical and biochemical geneticist primarily interested in inherited metabolic disorders and neurogenetics and dysmorphology. In his role as Director of the Inherited Metabolic Program he is deeply involved in all aspects related with the diagnosis, management and overall care of patients and families with these disorders. In addition, he is in charge of the education of young physicians and medical students in the field of IMD. As an educator, he is in charge of the medical biochemistry lecture series for the first year medical students at the Physicians & Surgeons Medical School at Columbia University paving the way for a new generations of brilliant medical students at Columbia University. Finally, his involvement with the diagnosis and care of patients with X-linked adrenoleukodystrophy has been one of his main accomplishments in the recent years, especially since the introduction of newborn screening in New York State. He has a been involved from the beginning in the development of the program and is active member of the NYS group of metabolic physicians taking care of these patients. In addtion he has been actively involved in all developments asscoiated with newborn screening for Krabbe disease and Pompe disease. Dr. Iglesias is rated as an Experienced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Hypotonia, Microcephaly, Achalasia Microcephaly Syndrome, and Cortical Dysplasia. Dr. Iglesias is board certified in Pediatrics, Clinical Genetics And Genomics (MD), and Clinical Biochemical Genetics. Dr. Iglesias is currently accepting new patients.

Tarun Sharma is an Ophthalmologist practicing medicine in New York, New York. Dr. Sharma is rated as an Advanced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Late-Onset Retinal Degeneration, X-Linked Juvenile Retinoschisis, Vitrectomy, and Trabeculectomy. Dr. Sharma is currently accepting new patients.

Stanley Chang is an Ophthalmologist practicing medicine in New York, New York. Dr. Chang is rated as an Advanced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Detachment, Vitrectomy, and Cataract Removal. Dr. Chang is currently accepting new patients.

Vlad Diaconita is an Ophthalmologist practicing medicine in New York, New York. Dr. Diaconita is rated as an Advanced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Retinopathy Pigmentary Mental Retardation, Neuroretinitis, Acatalasemia, Late-Onset Retinal Degeneration, and Vitrectomy. Dr. Diaconita is currently accepting new patients.

Amy Kontorovich is a Cardiologist practicing medicine in New York, New York. Dr. Kontorovich is rated as an Advanced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. She is also highly rated in 89 other conditions, according to our data. Her clinical expertise encompasses Pediatric Myocarditis, Cardiomyopathy, Familial Dysautonomia, and Myocarditis.

Dr. Barile is Professor of Ophthalmology, Zucker School of Medicine at Hofstra /Northwell, and Director of Ophthalmology Research, Manhattan Eye, Ear and Throat Hospital. He previously served as the John Wilson Espy MD Professor of Clinical Ophthalmology and Glaubinger Scholar in Retina Research at Columbia University. Dr. Barile has lectured widely, has authored or coauthored more than eighty publications, and is a member of numerous professional societies and organizations including the Macula and Retina Societies. Among several honors, Dr. Barile received an Achievement Award from the American Academy of Ophthalmology and a Senior Honor Award from the American Society of Retina Specialists. Dr. Barile is rated as an Experienced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Detachment, Retinal Vein Occlusion, and Vitrectomy. Dr. Barile is board certified in American Board Of Ophthalmology.

Kunal Dansingani is an Ophthalmologist practicing medicine in Great Neck, New York. Dr. Dansingani is rated as an Advanced provider by MediFind in the treatment of Retinopathy Pigmentary Mental Retardation. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Detachment, and Vitrectomy. Dr. Dansingani is board certified in American Board Of Ophthalmology.